We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There were no reports of serious adverse events with MCO ...

A first-in-class obesity drug, presented at the European Association for the Study of Diabetes meeting in Vienna, aims to reprogramme metabolism rather than suppress appetite – offering the potential ...

A new type of jab that tackles the underlying causes of obesity could help people maintain weight loss even if they stop taking it. The drug, which is called RES-010, is designed to block an RNA ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The therapy received five orphan designations from the ...

MCO-010 has received EMA Orphan designations for multiple retinal dystrophies and FDA RMAT designation for Stargardt disease, highlighting its potential to address unmet needs. EMA Orphan status ...

gMolecular Surgery Lab, Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA 94303, USA Stargardt disease (SD) is an inherited degenerative retinal disease ...

The completion of the full BLA submission is anticipated in early 2026 and is eligible for priority review under the program’s fast-track designation. Today Nanoscope Therapeutics announced its ...

Toyota Gazoo Racing Europe technical director David Floury has suggested the GR010 Hybrid could be set for a makeover for the 2026 FIA World Endurance Championship season to bring it in line with the ...

Capcom has a new Monster Hunter Wilds patch ready to address bugs on all platforms. While this doesn’t fix all of the game’s issues, it does target a few key annoying bugs that caused the game to ...

The Department of Education (DepEd) remains steadfast in promoting transparency, integrity, and accountability by making basic education data accessible to the public which empowers internal and ...

PEP-010 has received orphan drug designation for pancreatic cancer, emphasizing the need for novel treatments in this high-mortality disease. The peptide disrupts Caspase-9 and PP2A interaction, ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial evaluating ...